Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

J7633
HCPCS Code

2023 HCPCS
Billable/Valid Code

J7633 is a valid 2023 HCPCS Code that could be used to indicate Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram for reimbursement purposes.

J7633 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2007.

Short description for J7633 HCPCS code:

Budesonide non-comp con

HCPCS J7633

J7633 code information

HCPCS code:	J7633
Description:	BUDESONIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER 0.25 MILLIGRAM
Effective Date:	Jan 01, 2007
Added Date:	Jan 01, 2003
Termination Date:	HCPCS J7633 was terminated on Nov 30, -0001
Pricing indicator:	`51` - DRUGS
Multi Pricing indicator:	`A` - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY
Coverage code:	`C` - CARRIER JUDGMENT
BETOS code:	`D1G` -
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`1` - MEDICAL CARE `P` - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
Anesthesia BUQ:	0